Does smoking influence survival in cancer patients through effects on respiratory and vascular disease?

European Journal of Cancer Prevention

Volumn 15, Issue 1, 2006, Pages 87-90

  Clark, Taane G ^a,b   Murphy, Michael F G ^b   Hey, Kate ^b   Drury, Mark ^b   Cheng, K K ^c   Aveyard, Paul ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cancer; Cardiovascular disease; Prognosis; Respiratory disease; Smoking cessation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; DYING; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SMOKING CESSATION; SMOKING HABIT; UNITED KINGDOM; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RESPIRATORY TRACT DISEASES; RISK; SCOTLAND; SMOKING; SURVIVAL RATE; VASCULAR DISEASES;

EID: 30044451814     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000186634.81753.45     Document Type: Article

References (12)

1. Aveyard P, Adab P, Cheng KK, Wallace DMA, Hey K, Murphy MFG (2002). Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU Int 90:228-239.
2. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2000). Favourable and unfavourable effects on long term survival of radiotherapy for early breast cancer; an overview of the randomised trials. Lancet 355:1757-1770.
3. Gonzalez M, McCann F, Sugden E (2000). Should we discuss smoking histories with our cancer patients? Clin Oncol 12:195-196.
4. Gritz ER, Vidrine DJ, Lazev AB (2003). Smoking cessation in cancer patients: never too late to quit. In: Given C, Given B, Kozachik S, DeVoss V, editors. Evidence-based cancer care and prevention. Behavioral interventions. New York: Springer; (in press).
5. Kamholz SL (2004). Pulmonary and cardiovascular consequences of smoking. Med Clin N Am 88:1415-1430.
6. Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman SM, et al. (2001). The impact of smoking status, disease stage and index tumour site on second primary tumour incidence and tumour recurrence in the head and neck retinoid chemoprevention trial. Cancer Epi Biomarker Prev 10:823-829.
7. Lunn M, McNeil D (1995). Applying Cox regression to competing risks. Biometrics 51:524-532.
8. Munafo M, Rigotti N, Lancaster T, Stead L, Murphy M (2001). Occasional Review: Interventions for smoking cessation amongst hospitalised patients: a systematic review. Thorax 56:656-663.
9. Samet JM (1992). The health benefits of smoking cessation. Med Clin N Am 76:399-414.
10. Sioris T, Husgafvel-Pursiainen K, Karjalainen A, Anttila S, Kannio A, Salo JA, et al. (2000). Survival in operable non-small cell lung cancer: role of p53 mutations, tobacco smoking and asbestos exposure. Int J Cancer 86:590-594.
11. Wald NJ, Hackshaw AK (1996). Cigarette smoking: an epidemiological overview. Br Med Bull 52:3-11.
12. Yu GP, Ostroff JS, Zhang ZF, Tang J, Schantz SP (1997). Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detect Prev 21:497-509.